Published in Digestion on January 01, 1982
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
New somatostatin molecule for management of endocrine tumours. Gut (1985) 0.85
Epithelial response of the rat gastric mucosa to chronic superficial injury. Yale J Biol Med (1997) 0.84
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
The stomach is a source of leptin. Nature (1998) 3.33
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (1982) 3.10
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
Utilization of paraffin-embedded material for electron microscopy. Study of an A2-cell type microadenoma of the endocrine pancreas. Lab Invest (1970) 1.70
Somatostatin. Recent Prog Horm Res (1975) 1.67
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A (1982) 1.66
[The automatic determination of proteolytic activity of gastric juice]. Biol Gastroenterol (Paris) (1968) 1.60
Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A (1983) 1.57
[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51
Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature (1975) 1.50
Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology (1974) 1.38
Solid phase synthesis of somatostatin-28. Biochem Biophys Res Commun (1980) 1.34
Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature (1986) 1.33
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27
Early segregation of a neuronal precursor cell line in the neural crest as revealed by culture in a chemically defined medium. Cell (1983) 1.26
Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature (1981) 1.23
Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22
Inhibition of growth hormone release in humans by somatostatin. J Clin Endocrinol Metab (1973) 1.22
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc Natl Acad Sci U S A (1982) 1.19
Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc Natl Acad Sci U S A (1980) 1.18
Immunohistochemical detection of growth hormone-releasing factor in brain. Nature (1983) 1.15
Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. Arthritis Rheum (1994) 1.13
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.13
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis (2001) 1.09
Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07
Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A (1984) 1.06
Radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse. A selective effect of gastrin on parietal cell proliferation. Gastroenterology (1975) 1.06
Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology (1979) 1.04
Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology (1993) 1.04
Population kinetics of antral gastrin cells in the mouse. Gastroenterology (1976) 1.03
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03
The phosphaturic effect of sodium bicarbonate and acetazolamide in dogs. J Clin Invest (1968) 1.02
Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci (1983) 1.02
Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochem Biophys Res Commun (1982) 1.01
Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res (1977) 1.01
Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. Biochem Biophys Res Commun (1982) 1.01
Hypothalamic peptides: New evidence for "peptidergic" pathways in the C.N.S. Lancet (1975) 1.00
Stimulating effect of bombesin on the growth of gastrointestinal tract and pancreas in suckling rats. Gastroenterology (1986) 1.00
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun (1983) 0.99
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun (1983) 0.99
The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone. Biochem Biophys Res Commun (1973) 0.98
Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion (1979) 0.97
Isolation and chemical characterization of somatostatin-28 from rat hypothalamus. Regul Pept (1981) 0.97
Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas (1993) 0.97
Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci (1988) 0.97
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97
Isolation and characterization of rat pancreatic somatostatin. Endocrinology (1980) 0.96
High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regul Pept (1981) 0.96
Gastric HCO3-stimulated ATPase: evidence against its microsomal localization in rat fundus mucosa. Biochim Biophys Acta (1974) 0.96
C1-transport in gastric micorsomes. An ATP-dependent influx sensitive to membrane potential and to protein kinase inhibitor. J Biol Chem (1980) 0.95
Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology (1979) 0.95
Pulsatile growth hormone secretion: suppression by hypothalamic ventromedial lesions and by long-acting somatostatin. Science (1974) 0.95
Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun (1982) 0.94
Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. J Med Chem (1975) 0.94
Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochem Biophys Res Commun (1984) 0.93
Determination of histamine, methylhistamines and histamine-o-phthaldialdehyde complexes by two high-performance liquid chromatographic procedures. Application to biological samples. J Chromatogr (1983) 0.93
[Somatomedin inhibition of the growth hormone secretion stimulated by the hypothalamic factor somatocrinin or the synthetic peptide hpGRF]. C R Seances Acad Sci III (1982) 0.93
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
Pulsatile growth hormone release in the rat: failure to demonstrate a correlation with sleep phases. Endocrinology (1976) 0.93
Healing of experimental aneurysms. II: Platelet extracts can increase the thickness of the neointima at the neck of treated aneurysms. J Neuroradiol (1999) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney. Regul Pept (1990) 0.92
Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology (1992) 0.91
Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. Science (1982) 0.91
Parietal and chief cell populations in four cases of the Zollinger-Ellison syndrome. Gastroenterology (1972) 0.91
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer (1987) 0.91
Physiologic secretion of growth hormone and prolactin in male and female rats. Clin Endocrinol (Oxf) (1977) 0.91
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis (1999) 0.91
Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract. Cell Tissue Res (1994) 0.91
Isolation and characterization of hypothalamic peptide hormones. Curr Top Mol Endocrinol (1976) 0.90
Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy. J Histochem Cytochem (1992) 0.90
IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage (1996) 0.90
Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology (1982) 0.90
Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun (2001) 0.89
Isolation and characterization of rat hypothalamic somatostatin-14. Endocrinology (1981) 0.89
Inhibition of growth hormone secretion in the rat by synthetic somatostatin. Endocrinology (1974) 0.89
Pulsatile growth hormone, prolactin, and thyrotropin secretion in rats with hypothalamic deafferentation. Brain Res (1977) 0.89
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1. Biochem Biophys Res Commun (1984) 0.89
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci (1993) 0.88
Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol (1991) 0.88
Central inhibition of basal pancreatic and gastric secretions by beta-endorphin in rats. Gastroenterology (1980) 0.88
Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25. Biochem Biophys Res Commun (1980) 0.88
Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun (1983) 0.88
Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep (1982) 0.88
Increased insulin-like growth factor 1 production by human osteoarthritic chondrocytes is not dependent on growth hormone action. Arthritis Rheum (1995) 0.88
[Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.87
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol (1982) 0.87